Efficacy of vibegron in patients with overactive bladder: Multicenter prospective study of real-world clinical practice in Japan, SCCOP study 19-01.

Kimihito Tachikawa Yuki Kyoda Fumimasa Fukuta Ko Kobayashi Naoya Masumori

Published in: Lower urinary tract symptoms (2021)

In the real-world clinical setting, vibegron is effective and well-tolerated by OAB patients, including those switching therapy from antimuscarinics and mirabegron.

Keyphrases

end stage renal disease
clinical practice
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
stem cells
cross sectional
clinical trial
patient reported outcomes
patient reported